ALS Therapy Development Institute

URGENT: The COVID-19 epidemic is severely impacting the progress of ALS research at the ALS Therapy Development Institute. If you are able to give, will you please provide an immediate gift to fund our lab?

Donate Now

COVID-19: Impact on ALS Research

Tuesday, April 21, 2020

A Message From Our Chief Scientific Officer Regarding COVID-19

Monday, March 30, 2020

COVID-19 Seriously Impacting the Progress of ALS Research

Wednesday, March 25, 2020

COVID-19: We Are in This Together

Friday, March 20, 2020

COVID-19 Information for Those Impacted by ALS

More COVID-19 Updates

Who We Are

Our scientists discover and develop potential treatments for ALS, also known as Lou Gehrig's disease, a disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement. Led by drug development experts and people with ALS, we are 100% focused on finding effective treatments to slow and stop this disease.

ALS Research

What We're Doing

Our innovative and cutting-edge approaches have led to the identification of AT-1501, a promising treatment for ALS. We also pioneered the first ALS Precision Medicine Program to discover more potential treatments faster by working with people with ALS.

About Us

Why We Need Your Help

As a nonprofit biotech, we operate without regard to profit motive or politics. Our research is funded by a global network of supporters unified to end ALS. We're getting closer, but we need your help.

Help Fund Treatments

Two Ways You Can

Help Today

Start a Fundraiser

Donate

News & Events

ALS and Precision Medicine: Learning from Patients Worldwide

More ALS TDI News

A Current Day in the Life of ALS TDI's Chief Scientific Officer, Fernando Vieira, M.D.

More Research News

Jun

2020

My-State Trek

Full List of Events